PUBLISHER: Allied Market Research | PRODUCT CODE: 1566969
PUBLISHER: Allied Market Research | PRODUCT CODE: 1566969
Brucellosis Vaccines Market By Type , By Vaccine By Animal Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
The brucellosis vaccines market was valued at $0.2 billion in 2023, and is projected to reach $0.4 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033.
Brucellosis vaccine is a critical tool used in the prevention and control of brucellosis, a zoonotic bacterial infection caused by Brucella species. This disease affects various livestock, including cattle, sheep, and goats, leading to reproductive failures such as abortions, reduced fertility, and significant economic losses in the agricultural sector. In humans, brucellosis can cause a range of symptoms, from mild flu-like illness to severe, chronic conditions. Vaccination of livestock is a cornerstone in reducing the transmission of Brucella from animals to humans, thus playing a vital role in public health and food safety.
The growth of the global brucellosis vaccines market is driven by rise in incidence of brucellosis in livestock, particularly in regions with significant agricultural activity, and increase in awareness among farmers and livestock owners about the importance of vaccination in preventing brucellosis. According to a study published by the National Institutes of Health-one of the world's foremost medical research centers-brucellosis is one the most common zoonotic diseases affecting 500,000 cases annually. As the global demand for meat and dairy products grows, there is a corresponding increase in the need to protect livestock from diseases like brucellosis, further driving the brucellosis vaccine market. Moreover, with brucellosis being a zoonotic disease that can be transmitted to humans, there is an increasing focus on controlling the disease in animals to protect human health, which, in turn, fosters the demand for vaccines. Furthermore, increase in trend of regional and national vaccination campaigns, particularly in countries where brucellosis is a significant public health issue, is notably contributing toward the market growth. In addition, emphasis on the One Health concept, which focuses on the interconnectedness of human, animal, and environmental health, is influencing the brucellosis vaccination market. This holistic approach is leading to integrated efforts to control brucellosis in both animals and humans, particularly in regions where the disease is endemic. However, high cost associated with development of new and effective brucellosis vaccines is hampering the growth of the global market. In addition, the emergence of vaccine-resistant strains of Brucella due to genetic variability has reduced the effectiveness of existing vaccines, which significantly restrained the market growth. On the contrary, advancements in vaccine technology, such as the development of more effective and safer vaccines, are contributing to market growth by improving the efficacy of disease control measures. Moreover, advances in biotechnology are driving innovations in vaccine production, including the use of recombinant DNA technology and other molecular techniques. These innovations are enhancing the efficacy and safety of brucellosis vaccines, making them more accessible and scalable.
The global brucellosis vaccines industry is segmented into type, vaccine, animal type, end user, and region. By type, the market is divided into RBS1, S19, and B19. As per vaccine, it is segregated into DNA vaccine, subunit vaccine, vector vaccine, and recombinant vaccine. By animal type, it is fragmented into cattle, sheep, and goat. Depending on end user, it is fragmented into veterinary hospitals & clinics, animal care centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the RBS1 segment dominated the market share in 2023.
As per vaccine, the DNA vaccine segment was the major shareholder in the market in 2023.
On the basis of animal type, cattle emerged as the leading segment in 2023.
Depending on end user, the veterinary hospitals & clinics segment garnered the largest share in 2023.
Region wise, North America held the dominant position in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global brucellosis vaccines market include Ceva Poultry, Colorado Serum Company, Creative Biolabs, CZ Vaccines, Fivet Animal Health, Hester Biosciences Limited, Indian Immunologicals Ltd, Jordan Bio-industries Center, Laboratories Tornel, and Merck & Co., Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Type
- RBS1
- S19
- B19
By Vaccine
- DNA Vaccine
- Subunit Vaccine
- Vector Vaccine
- Recombinant Vaccine
By Animal Type
- Cattle
- Sheep
- Goat
By End User
- Veterinary Hospitals and Clinics
- Animal Care Centers
- Other
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Ceva Poultry
- Colorado Serum Company
- Creative Biolabs
- CZ Vaccines
- Fivet Animal Health
- Hester Biosciences Limited
- Indian Immunologicals Ltd
- Jordan Bio-industries Center
- Laboratories Tornel
- Merck & Co., Inc.
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: BRUCELLOSIS VACCINES MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. RBS1
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. S19
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. B19
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
CHAPTER 5: BRUCELLOSIS VACCINES MARKET, BY VACCINE
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Vaccine
- 5.2. DNA Vaccine
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Subunit Vaccine
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Vector Vaccine
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Recombinant Vaccine
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
CHAPTER 6: BRUCELLOSIS VACCINES MARKET, BY ANIMAL TYPE
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Animal Type
- 6.2. Cattle
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Sheep
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Goat
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
CHAPTER 7: BRUCELLOSIS VACCINES MARKET, BY END USER
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
- 7.2. Veterinary Hospitals And Clinics
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
- 7.3. Animal Care Centers
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
- 7.4. Other
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
CHAPTER 8: BRUCELLOSIS VACCINES MARKET, BY REGION
- 8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
- 8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Type
- 8.2.3. Market Size and Forecast, By Vaccine
- 8.2.4. Market Size and Forecast, By Animal Type
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Brucellosis Vaccines Market
- 8.2.7.1. Market Size and Forecast, By Type
- 8.2.7.2. Market Size and Forecast, By Vaccine
- 8.2.7.3. Market Size and Forecast, By Animal Type
- 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Brucellosis Vaccines Market
- 8.2.8.1. Market Size and Forecast, By Type
- 8.2.8.2. Market Size and Forecast, By Vaccine
- 8.2.8.3. Market Size and Forecast, By Animal Type
- 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Brucellosis Vaccines Market
- 8.2.9.1. Market Size and Forecast, By Type
- 8.2.9.2. Market Size and Forecast, By Vaccine
- 8.2.9.3. Market Size and Forecast, By Animal Type
- 8.2.9.4. Market Size and Forecast, By End User
- 8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Type
- 8.3.3. Market Size and Forecast, By Vaccine
- 8.3.4. Market Size and Forecast, By Animal Type
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. Germany Brucellosis Vaccines Market
- 8.3.7.1. Market Size and Forecast, By Type
- 8.3.7.2. Market Size and Forecast, By Vaccine
- 8.3.7.3. Market Size and Forecast, By Animal Type
- 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. France Brucellosis Vaccines Market
- 8.3.8.1. Market Size and Forecast, By Type
- 8.3.8.2. Market Size and Forecast, By Vaccine
- 8.3.8.3. Market Size and Forecast, By Animal Type
- 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. UK Brucellosis Vaccines Market
- 8.3.9.1. Market Size and Forecast, By Type
- 8.3.9.2. Market Size and Forecast, By Vaccine
- 8.3.9.3. Market Size and Forecast, By Animal Type
- 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Italy Brucellosis Vaccines Market
- 8.3.10.1. Market Size and Forecast, By Type
- 8.3.10.2. Market Size and Forecast, By Vaccine
- 8.3.10.3. Market Size and Forecast, By Animal Type
- 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. Spain Brucellosis Vaccines Market
- 8.3.11.1. Market Size and Forecast, By Type
- 8.3.11.2. Market Size and Forecast, By Vaccine
- 8.3.11.3. Market Size and Forecast, By Animal Type
- 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest of Europe Brucellosis Vaccines Market
- 8.3.12.1. Market Size and Forecast, By Type
- 8.3.12.2. Market Size and Forecast, By Vaccine
- 8.3.12.3. Market Size and Forecast, By Animal Type
- 8.3.12.4. Market Size and Forecast, By End User
- 8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Type
- 8.4.3. Market Size and Forecast, By Vaccine
- 8.4.4. Market Size and Forecast, By Animal Type
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. Japan Brucellosis Vaccines Market
- 8.4.7.1. Market Size and Forecast, By Type
- 8.4.7.2. Market Size and Forecast, By Vaccine
- 8.4.7.3. Market Size and Forecast, By Animal Type
- 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. China Brucellosis Vaccines Market
- 8.4.8.1. Market Size and Forecast, By Type
- 8.4.8.2. Market Size and Forecast, By Vaccine
- 8.4.8.3. Market Size and Forecast, By Animal Type
- 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. Australia Brucellosis Vaccines Market
- 8.4.9.1. Market Size and Forecast, By Type
- 8.4.9.2. Market Size and Forecast, By Vaccine
- 8.4.9.3. Market Size and Forecast, By Animal Type
- 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. India Brucellosis Vaccines Market
- 8.4.10.1. Market Size and Forecast, By Type
- 8.4.10.2. Market Size and Forecast, By Vaccine
- 8.4.10.3. Market Size and Forecast, By Animal Type
- 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. South Korea Brucellosis Vaccines Market
- 8.4.11.1. Market Size and Forecast, By Type
- 8.4.11.2. Market Size and Forecast, By Vaccine
- 8.4.11.3. Market Size and Forecast, By Animal Type
- 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Brucellosis Vaccines Market
- 8.4.12.1. Market Size and Forecast, By Type
- 8.4.12.2. Market Size and Forecast, By Vaccine
- 8.4.12.3. Market Size and Forecast, By Animal Type
- 8.4.12.4. Market Size and Forecast, By End User
- 8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Type
- 8.5.3. Market Size and Forecast, By Vaccine
- 8.5.4. Market Size and Forecast, By Animal Type
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Brucellosis Vaccines Market
- 8.5.7.1. Market Size and Forecast, By Type
- 8.5.7.2. Market Size and Forecast, By Vaccine
- 8.5.7.3. Market Size and Forecast, By Animal Type
- 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. Saudi Arabia Brucellosis Vaccines Market
- 8.5.8.1. Market Size and Forecast, By Type
- 8.5.8.2. Market Size and Forecast, By Vaccine
- 8.5.8.3. Market Size and Forecast, By Animal Type
- 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. South Africa Brucellosis Vaccines Market
- 8.5.9.1. Market Size and Forecast, By Type
- 8.5.9.2. Market Size and Forecast, By Vaccine
- 8.5.9.3. Market Size and Forecast, By Animal Type
- 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. Rest of LAMEA Brucellosis Vaccines Market
- 8.5.10.1. Market Size and Forecast, By Type
- 8.5.10.2. Market Size and Forecast, By Vaccine
- 8.5.10.3. Market Size and Forecast, By Animal Type
- 8.5.10.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top Winning Strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
- 10.1. Ceva Poultry
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
- 10.2. Colorado Serum Company
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
- 10.3. Creative Biolabs
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
- 10.4. CZ Vaccines
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
- 10.5. Fivet Animal Health
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
- 10.6. Hester Biosciences Limited
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
- 10.7. Indian Immunologicals Ltd
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
- 10.8. Jordan Bio-industries Center
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
- 10.9. Laboratories Tornel
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
- 10.10. Merck And Co., Inc.
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments
